Experience the World of Interconnected Security on IDEMIA’s Booth at Milipol Paris (november 19-22, 2019)
Today, more than ever before, new digital and biometric technologies represent the future of public security to provide trusted and reliable security solutions based on identity, and to maintain at the same time efficiency and convenience that ease citizens’ lives.
At Milipol Paris, IDEMIA will showcase its cutting-edge technologies in three fields so that visitors can experience the whole future of security.
- Securing major events
Thanks to its 40 years of strong relationships with the world’s leading law enforcement agencies and governments, IDEMIA has developed an in-depth understanding of the processes and procedures involved to ensure security at major events. The company not only provides the most innovative, biometric technologies – it also ensures interoperability of systems for a smooth and efficient running of events.
IDEMIA’s innovative and intelligent systems use highly accurate algorithms integrated in its video and intelligence analytics to help secure major event, critical buildings, and infrastructures such as malls, hospitals and airports. IDEMIA’s range of solutions helps operators prevent offences by identifying persons or objects of interest and investigate faster once an event occurs.
- Securing borders
Travelers can cross a country’s borders by sea, air or road, and governments need to ensure that each border is secure. Government agencies face conflicting objectives: securing borders while facilitating an increasing flow of travelers crossing them. IDEMIA’s interoperable and fully scalable suite of products and services helps governments create a border control solution best adapted to their needs. Combining API/PNR information with a traveler’s multi-biometrics (fingerprint, face and iris) makes the border crossing process almost foolproof. The company has designed a comprehensive traveler data collection and risk assessment solution to improve the border management process, in compliance with regulations and respect of privacy.
- Securing the community
Crime prevention forms the very basis for ensuring safe citizens and cities. In times of possible insecurity, assessing the threat level of individuals is crucial in order to prevent attacks. Law enforcement agents need tools that can speed up the decision-making process on whether to act or not. An important step to overcome this challenge of time and resources is to provide officers with advanced mobile tools and equipment that will help them conduct identification on the beat. IDEMIA has developed a mobile app that uses the camera of a mobile phone to identify a suspect by matching the fingerprints or the face of the suspect automatically against a central database. Adding more biometric solutions to smartphones will save police officers valuable time and effort.
“Biometric technologies are a key contributor to resolving today's security challenges and improving the way we want to live in our cities safely. It indeed provides the ideal match between the high accuracy needed by public authorities and the level of convenience required by citizens living in a digital world. Through highly secure, non-intrusive solutions, we are helping authorities around the world create safer places to live.” said Philippe BARREAU, Executive Vice President for Public Security & Identity activities at IDEMIA.
Take a tour of our Experience, Booth #D168 - Hall 5
to experience the future of safe cities by IDEMIA.
Our experts look forward to meeting you!
IDEMIA’s innovations on the booth:
- IDEMIA Traveler Analytics Suite: smart analytics for your border management strategies.
- Video and Intelligence Analytics: our offer supports security officers in identifying and tracking persons or objects of interest
- Intuitive tactical control & command software integrating video analytics platform allowing operators to react on an alert immediately
- Mobile Biometric Check, to perform in-the-field biometric checks with your smartphone
- MBIS, the innovative Automated Biometric Identification System to meet the growing need for real-time identification of suspects and criminals,
- MESTAfusion, to detect and enforce different types of traffic violations to improve safety and respectful behavior on the roads
- MESTAcontrol, the Intelligent Transportation System back office solution to gather and process traffic management data for safer roads
About IDEMIA
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
With 13,000 employees around the world, IDEMIA serves clients in 180 countries.
For more information, visit www.idemia.com / Follow @IDEMIAGroup on Twitter
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191119005432/en/
Contact information
Press
Hanna SEBBAH - idemia@havas.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom